Three dimensional vaginal tissue model containing immune cells

Details Three dimensional vaginal tissue model containing immune cells Three dimensional vaginal tissue model containing immune cells

2005-09-13

2005-09-13

Witz, Jean C. (Department: 1651)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of co-culturing cells

C424S093700, C435S377000

Reexamination Certificate

active

06943021

ABSTRACT:
Disclosed is a cervico-vaginal tissue equivalent comprised of vaginal epithelial cells and immune cells, cultured at the air-liquid interface. The tissue equivalent is capable of being infected with a sexually transmitted pathogen such as a virus (e.g., HIV), a bacteria, a helminthic parasite, or a fungus. The tissue equivalent is also capable of undergoing an allergic-type reaction or an irritant-type reaction. The tissue equivalent is characterized as having nucleated basal layer cells and nucleated suprabasal layer cells, and further as having cell layers external to the suprabasal layer progressively increasing in glycogen content and progressively decreasing in nuclei content. Immune cells of the tissue equivalent are primarily located in the basal and suprabasal layers. Also disclosed are methods for producing the tissue equivalent. The methods involve providing vaginal epithelial cells and immune cells, seeding the cells onto a porous support, and co culturing the seeded cells at the air-liquid interface under conditions appropriate for differentiation. One such method disclosed is for generation of the tissue equivalent in serum free medium. Specific cells from which the tissue equivalent is generated, and also specific preferred components of the medium in which the tissue equivalent is generated are provided. Also disclosed is a cervico-vaginal tissue equivalent produced by the methods disclosed herein.

REFERENCES:
patent: 4963489 (1990-10-01), Naughton et al.
patent: 5032508 (1991-07-01), Naughton et al.
patent: 5160490 (1992-11-01), Naughton et al.
patent: 5266480 (1993-11-01), Naughton et al.
patent: 5443950 (1995-08-01), Naughton et al.
patent: 5478739 (1995-12-01), Slivka et al.
patent: 5512475 (1996-04-01), Naughton et al.
patent: 5516680 (1996-05-01), Naughton et al.
patent: 5516681 (1996-05-01), Naughton et al.
patent: 5518915 (1996-05-01), Naughton et al.
patent: 5541107 (1996-07-01), Naughton et al.
patent: 5578485 (1996-11-01), Naughton et al.
patent: 5580781 (1996-12-01), Naughton et al.
patent: 5627025 (1997-05-01), Steinman et al.
patent: 5698436 (1997-12-01), Morgan et al.
patent: 5750397 (1998-05-01), Tsukamoto et al.
patent: 5763197 (1998-06-01), Tsukamoto et al.
patent: 5766944 (1998-06-01), Ruiz
patent: 5785964 (1998-07-01), Naughton et al.
patent: 5830682 (1998-11-01), Moore
patent: 5858721 (1999-01-01), Naughton et al.
patent: 5861153 (1999-01-01), Schmidt et al.
patent: 5962325 (1999-10-01), Naughton et al.
patent: 5968546 (1999-10-01), Baur et al.
patent: 6022743 (2000-02-01), Naughton et al.
Delvenne et al., Vaccine 19: 2557-2564 (2001).
Aebischer, F. et al. “Organotypic raft cultures for the in vitro evaluation of vaginal microbicidal agents”, Sex. Trans. Dis., 24: 69-76 (1997).
Ayehunie, S. et al. “Reconstruction of vaginal tissue model for HIV infection”, Abstract and presentation materials for Nobel Symposium #119:Global HIV therapeutics—HIV vaccinesStockholm, Sweden (Jun. 7-9, 2001).
Ayehunie, S. et al., “In vitro reconstructed ectocervical-vaginal tissue model”, Abstract and presentation materials for 2ndAnnual Harvard Medical School Centers for AIDS Research Symposium: International Efforts in HIV/AIDS Treatment and Prevention (Mar. 4, 2002).
Bernstam, L.I. et al., “Keratinocytes grown at the air-liquid interface”,In Vitro Cellular& Development Biology, 22 (12):695-705 (1986).
Blauvelt, A., “The role of skin dendritic cells in the initiation of Human Immunodeficiency Virus infection”, Am. J. Med., 102 (5B): 16-20 (1997).
Boyce, S.T. et al., “Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture”,Journal of InvestigativeDermatology, 81:33s-40s (1983).
Buchanan, D.L. et al., “Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification”, Endocrinol., 139(10):4345-4352 (1998).
Cameron, P. et al., “Dendritic cells and the replication of HIV-1”,J. Leukocyte Biol., 59: 158-171 (1996).
Cannon, C.L. et al., “New epidermal model for dermal irritancy testing”,Toxic. in Vitro, 8(4):889-891 (1994).
Caux, C. et al., “GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells”, Nature, 360:258-261 (1992).
Cohen, M.S., “Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis”, Lancet, 351 (suppl III):sm5-sm7 (1998).
Collins, K.B. et al., “Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract”, Nature Medicine, 6: 475-479 (2000).
Conti, C.J. et al. “Regulation of cultured rat vaginal epithelial cells by 17β-estradiol and progesterone”, J. Steroid Biochem., 24(3):747-751 (1986).
Doillon, C.J. et al., “Method of growing vaginal mucosal cells on a collagen sponge matrix”,J. Reproduct. Med., 35(3):203-207 (1990).
Esche, C. et al., “Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand”,J. Invest. Dermatol., 113(6):1028-1032 (1999).
Furuta, Y. et al., “Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120”, Proc. Natl. Acad Sci. USA, 91: 12559-12563 (1994).
Granelli-Piperno, A. et al., “Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T-cells”, Curr. Biol., 9:21-29 (1999).
Greenhead, P. et al,. “Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides”, J. of Virol., 74(12):5557-5586 (2000).
Howell, A.L. et al., “Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract”, J. Virol., 71:3498-3506 (1997).
Hu, J. et al., “Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of the rhesus monkeys”,Lab. Invest., 78: 435-451 (1998).
Iguchi, T. et al., “Growth of mouse vaginal epithelial cells in culture: effect of sera and supplemented serum-free medium”, In Vitro Cell. Dev. Biol., 23(8):535-540 (1987).
Kawamura, T., et al., “Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants,” J. Exp. Med., 192 (10):1491-1500 (2000).
Klausner, M., et al., “Intra- and interlaboratory reproducibility of epiderm, an in vitro model for dermal irritancy testing”, InAdvances in Animal Alternatives for Safety and Efficacy Testing, eds. Salem, H., Katz, S.A., Taylor & Francis, Washington, DC, pp. 347-357 (1997).
Klausner, M., et al., “Human tissue model for heterosexual HIV infection” Abstract, Grant No. 1R43AI047792-01, Retrieved from the Internet: http://crisp.cit.nih.gov .
Mells, G.B., et al., “[Role of pH as a regulator of vaginal physiological environment]”,MinervaGinecol., 52(4):111-121 (2000) [Italian. Abstract only.].
Meyers, C. et al., “Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation”,Science257:971-973 (1992).
Mosmann, T., “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays”,J. Immunol. Meth. 65(1-2):55-63 (1983).
Ozawa, S. et al., “Effect of certain growth factors on proliferation in serum-free collagen gel culture of vaginal epithelial cells from prepuberal mice exposed neonatally to diethylstilbestrol”, Proc. Soc. Exper. Biol. Med., 198:760-763 (1991).
Phillips, D.M. et al., “Mechanism of monocyte-macrophage-mediated transmission of HIV”,AIDSRes. Hum. Retroviruses, 14 Suppl 1.:S67-70 (1998).
Shattock, R.J. et al.,

Affiliated with

Also associated with

Rating

Three dimensional vaginal tissue model containing immune cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Three dimensional vaginal tissue model containing immune cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Three dimensional vaginal tissue model containing immune cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3407984